Bedaquiline (Sirturo)

Synonym(s): R207910

Class: Diarylquinoline

Details of activity:	Mycobacterium abscessus. Used to treat active tuberculosis
Institute where first reported:	Janssen Pharmaceutica, Belgium
Year first mentioned:	2004
Highest developmental phase:	Approved by FDA in 2012
Development status:	Approved

Chemical structure(s):
Canonical SMILES:	CN(C)CC[C@@](C1=CC=CC2=C1C=CC=C2)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O
Isomeric SMILES:	CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O
InChI:	InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1
InChI Key:	QUIJNHUBAXPXFS-XLJNKUFUSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/5388906

External links:
Guide to Pharmacology:	bedaquiline
Main Source:	https://aac.asm.org/content/63/8/e00827-19